Abstract:Key Points A large proportion of genomic variation might be associated with human disease phenotypes. New approaches should improve our understanding of this variation and its functional significance. Because there is insufficient guidance for molecular epidemiologists to optimally select variants for an epidemiology study, methods that prioritize the choice of genetic variants need to be included in molecular epidemiological studies. Laboratory-based evidence about the functional significance of a genetic variant can provide the strongest evidence for the functional role of a genetic variant, but these studies are difficult to mount on the scale that may be required for characterizing all human genetic variants, and their results might not always reflect in vivo genotype function in humans. Novel approaches to assessing the function of genetic variants are required to provide molecular epidemiological association studies with the information that is required to choose candidate genes and variants in these genes for association studies, and to optimally interpret the results of observed associations. Novel experimental approaches that might be informative, include the HaploCHIP method, gene tagging, gene trapping, N -ethyl- N -nitrosourea (ENU) mutagenesis, proteomics methods and evaluation of epigenetic mechanisms that assess genotype function. Non-laboratory-based approaches for assessing SNP function should also be considered. These approaches include those that use evolutionary similarity or structural effects of genetic variants, such as those implemented in the SIFT, PolyPhen or CODDLE algorithms. Population and evolutionary genetics data can be directly incorporated into association studies to optimize the identification of genes that are causally related to disease risk. The 'set association' approach is one example of this method. We propose an algorithm that can be useful in determining when a genetic variant might be functionally significant. This algorithm can be applied in the design and interpretation of molecular epidemiological association studies to maximize the potential that truly causative associations can be identified.

The functional genomics laboratory: functional validation of genetic variants

Assessing the function of genetic variants in candidate gene association studies

Consultation informs strategies to improve functional evidence use in variant classification

Understanding genetic variants in context

From variant to function in human disease genetics

Functional characterization of all missense variants and comparison to in silico models of pathogenicity

Functional evaluation of rare variants in complement factor I using a minigene assay

Utilizing ClinGen gene‐disease validity and dosage sensitivity curations to inform variant classification

Beyond the exome: what's next in diagnostic testing for Mendelian conditions

Searching PubMed for articles relevant to clinical interpretation of rare human genetic variants

Automated validation of genetic variants from large databases: ensuring that variant references refer to the same genomic locations

A Novel Statistical Method for Interpreting the Pathogenicity of Rare Variants

Exploring noncoding variants in genetic diseases: From detection to functional insights

Understanding the characteristic of single nucleotide variants

Avoiding Pitfalls in Molecular Genetic Testing

Clinical Utility of Protein Language Models in Resolution of Variants of Uncertain Significance in KCNQ1, KCNH2, and SCN5A Compared With Patch-Clamp Functional Characterization

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

Clinical and Laboratory Interpretation of Mitochondrial Mrna Variants

Genetic Diagnosis in Hereditary Hemochromatosis: Discovering and Understanding the Biological Relevance of Variants

Functional categorization of gene regulatory variants that cause Mendelian conditions

Variant functional assessment in Drosophila by overexpression: what can we learn?